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Lymphocryptovirus (LCV) is one of the major gena in the herpesvirus family and is
widely disseminated among primates. LCVs of human and rhesus macaques are
shown to be causative agents of a number of malignant diseases including lymphoma
and carcinoma. Bonobos (Pan paniscus) are highly endangered and the least studied
species of the great apes. Considering the potential pathogenicity of the LCV that
might threaten the fate of wild bonobos, population-based epidemiological information
in terms of LCV prevalence in different location of Bonobo’s habitats will help propose
improved conservation strategies for the bonobos. However, such data are not available
yet because it is very difficult to collect blood samples in the wild and thus virtually
impossible to conduct sero-epidemiological study on the wild ape. In order to overcome
this issue, we focused on evaluating anti-LCV IgA in the feces of bonobos, which are
available in a non-invasive manner. Preliminary study showed that anti-LCV IgA but not
IgG was efficiently and reproducibly detected in the feces of captive chimpanzees. It
is noteworthy that the fecal IgA-positive individuals were seropositive for both anti-LCV
IgG and IgA and that the IgA antibodies in both sera and feces were also detectable by
Western blotting assay. These results indicate that the detection of fecal anti-LCV IgA
is likely a reliable and feasible for epidemiological surveillance of LCV prevalence in the
great apes. We then applied this method and found that 31% of wild bonobos tested
were positive for anti-LCV IgA antibody in the feces. Notably, the positivity rates varied
extensively among their sampled populations. In conclusion, our results in this study
demonstrate that LCV is highly disseminated among wild bonobos while the prevalence
is remarkably diverse in their population-dependent manner.
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INTRODUCTION
Genetic studies have shown that chimpanzees and bonobos
diverged within the last million years or so (Becquet
and Przeworski, 2007; Hey, 2010; Takemoto et al., 2015).
Chimpanzees remain widespread in tropical Africa, occurring in
a variety of habitats, ranging from tropical forests to savannah
mosaics. Estimates of total surviving numbers have increased
from about 200,000 in the 1980s to a maximum of approximately
300,000 in 2003 (Oates, 2006). This growth in population is due
in large part to conservation efforts by humans. By contrast,
bonobos inhabit only Democratic Republic of the Congo (DRC);
they are the least studied species of the great apes, and efforts to
protect them and their habitats were significantly hindered as a
result of civil war spanning the late 1990s and early 2000s (Vogel,
2000). Prior to the civil war, their population was estimated
at around 29,500–50,0001. Their numbers have likely been
reduced to a half of pre-war estimates as a result of habitat loss
and concurrent increases in hunting over the last two decades
(Nackoney et al., 2014). Due to limitations in both research and
conservation in bonobo habitats, we still understand little in
terms of what ecological factors (disease, habitat fragmentation,
hunting, resource distribution, etc.) play the most important
roles in their health and mortality. It is critical to continue
ecological studies regarding endangered wild bonobos in order
to better understand what factors are most important in their
survival (Hickey et al., 2013).
In the last decade, the connection between African great
apes and emerging diseases such as AIDS, malaria, and Ebola
has gained considerable attention, as it relates to global health
and great ape conservation (Ryan and Walsh, 2011). Wild
populations of gorillas and chimpanzees are threatened by a
diverse array of virulent pathogens, including Ebola virus (Walsh
et al., 2003; Bermejo et al., 2006; Le Gouar et al., 2009), simian
immunodeficiency virus (SIV; Keele et al., 2006, 2009), in
addition to a variety of human respiratory viruses (Skiadopoulos
et al., 2002; Kaur et al., 2008; Kondgen et al., 2008; Szentiks et al.,
2009). Bermejo et al. (2006) estimated a loss of approximately
5000 gorillas in West Africa due to endemic Ebola outbreaks
in 2002/2003. SIV isolated from chimpanzees (SIVcpz) is now
known to be pathogenic in chimpanzees (Keele et al., 2009).
Lymphocryptovirus (LCV) belongs to the genus
gammaherpesvirus. Much like SIV and malaria, LCV
usually exhibits latent infection, where stress and/or immune
suppression can cause both viral expression and subsequent
onset of a variety of diseases (Mühe and Wang, 2015). LCV is
widely disseminated among primates, including humans and
chimpanzees (Mühe and Wang, 2015). Epstein–Barr virus (EBV)
is a widely recognized human-specific LCV and is a causative
agent of infectious mononucleosis, Hodgkin’s lymphoma,
Burkitt’s lymphoma, and nasopharyngeal carcinoma (Macsween
and Crawford, 2003). LCV is naturally infected with great
apes including chimpanzees and gorillas and is closely related
with EBV in terms of genomic organization and biological
properties (Rivailler et al., 2002a,b). It is therefore reasonable to
1http://www.iucnredlist.org/details/15932/0
assume that the LCV may also be pathogenic to the great apes
as natural hosts. So far epidemiological information regarding
LCV prevalence in wild bonobos is not available. Considering
the potential pathogenicity of the LCV that might threaten the
fate of wild bonobos, in the present study we aimed at examining
the prevalence of LCV in wild bonobos, which may help propose
improved conservation strategies for the bonobos. However, it
was not possible to perform usual serological surveillance since
sera samples of the bonobos were unavailable. A previous report
showed that some of EBV-infected humans became positive
for anti-EBV IgA (Hanlon et al., 2014), which led us to come
up with an idea that anti-LCV IgA could be detectable in the
feces. In order to test the possibility, we needed to overcome
the following hurdles; (i) if the great apes infected with LCV
could become positive for IgA as well as IgG against LCV in sera
similar to human cases, (ii) if the anti-LCV IgA level could be
correlated with that of IgG in sera, considering the possibility
that individuals infected with LCV were negative for anti-LCV
IgA while were positive for anti-LCV IgG, and (iii) if the IgA
and/or IgG could be efficiently eluted and detectable in the
feces. In our recent pilot study of serological surveillance toward
zoonotic and anthropozoonotic agents in captive chimpanzees
at Primate Research Institute, Kyoto University (KUPRI), most
of the chimpanzees were seropositive for LCV (Kooriyama et al.,
2013). Taking these issues into consideration, we sought to
address the above questions.
MATERIALS AND METHODS
Animals
This study was conducted under the guidelines provided
by KUPRI after the approval of Animal Welfare and Care
Committee in Kyoto University. The chimpanzees employed
in this study were kept in indoor-outdoor enclosure in
KUPRI (Matsuzawa, 2003, 2006). Individual information of each
chimpanzee is described in our previous report (Kooriyama et al.,
2013). Chimpanzees were used for behavioral, psychological,
and evolutional study and their health condition was monitored
daily and also by a periodical health examination. None of these
chimpanzees were previously vaccinated against any pathogens.
We observed bonobos (Pan paniscus) in Wamba, Tshuapa-
Lomami-Lualaba landscape (TL2), Lomako, and Lake Tumba
in Congo (Kawamoto et al., 2013). Research permission:
MIN.RS/SG/003/2010 (Wamba), 024/ICCN/BP-MA/2010 (TL2),
008//MINRS/CREF/MAB/DG/01MNIK/2011 (Lac Tumba),
051/ICCN/DG/ADG/KV/2011 (Lomako).
Sample Collection
Blood samples from captive chimpanzees were collected
when each chimpanzee was anesthetized for periodical health
examinations between 2007 and 2012. The chimpanzees were
anesthetized with a combination of ketamine hydrochloride
(Ketalar, Sankyo-Parke-Davis & Co., Inc., Japan, 3.5 mg/kg) and
medetomidine hydrochloride (Domitor Meiji Seika Kaisha, Ltd,
Tokyo, Japan, 0.035 mg/kg) with or without premedication with
oral midazolam (1 mg/kg) or droperidol (0.2 mg/kg). Anesthesia
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was maintained with isoflurane (Isoflu, Dainippon Sumitomo
Pharma, Co., Ltd, Osaka, Japan) or sevoflurane (Sevoflo,
Dainippon Sumitomo Pharma, Co., Ltd, Osaka, Japan) when
necessary. Sera were separated from the blood by centrifugation
at 3,000 g for 20 min, and then analyzed within a day or
stored at −80◦C. Fecal samples from these chimpanzees were
also collected into 50 ml tubes, and then stored at −80◦C until
extraction and purification.
Fecal Samples of wild bonobos were collected from four
distinct populations in DRC. Wamba population is situated the
north central of Congo basin in Luo Scientific Reserve (Furuichi
et al., 2012). The three study groups, E1, PE, and PW, ranged from
mainly primary or old secondary rainforest and swamp forest
but also included young secondary forest and cultivated fields
near the villages (Hashimoto et al., 1997; Terada et al., 2015). All
members of the three groups were identified (Furuichi et al., 2012;
Sakamaki et al., 2015). The Iyemba study site, located within the
greater Lomako Reserve, is located at about 200 km to the west
of the Wamba area. The Iyemba study site is mainly composed
of undisturbed primary forest with sub-canopy dominated by the
presence of Marantacea species (e.g., Haumania liebrechtsiana).
Small streams run through the site, but swamp and seasonally
inundated forest are uncommon, in contrast to other study
sites with more heterogeneity and forest mosaic compositions,
such as Wamba and Lui Kotal (Dupain et al., 2000; Hohmann
and Fruth, 2003; Terada et al., 2015). We collected samples
from two neighboring groups in Iyemba and Tolinda sites that
are approximately 9 km apart. The Lac Tumba population is
located near the Western limits of bonobo habitat in Congo basin
(Inogwabini et al., 2008). The Bokonzoli and Botuwali sites, south
of Lake Tumba, were surveyed. TL2 lies on the eastern limits
of bonobo range2. Fecal Samples of wild bonobos were collected
from regions around Katopa, Oluo, and Obenge campsites and
near Bafundo village. The southern area of TL2 is occupied with
savanna-forest mosaic vegetation.
Our methods for collection of bonobo feces varied according
to the degree of their habituation. Since feces decay and disappear
quickly, normally less than a half day after defecation in tropical
forests, we collected fresh samples during our direct observation
and placed into 50 ml tubes containing silica gel (Wako). For
well-habituated communities, such as the Wamba E1 group,
parties were followed from nest to nest everyday and feces
were collected immediately following observation of defecation.
During detailed behavioral follows, as with the Wamba E1 group,
the names of individuals were recorded for each sample; we
collected samples from each individual of the E1 group over a
2 months long survey. The Iyemba group was semi-habituated
at the time of collection and individual identification was not
always possible. Fecal samples were collected fresh from beneath
night nests that had been located the previous evening. Samples
were collected in this manner four times at Iyemba, and once
in Tolinda during 1-month survey. In the other two sites, Lac
Tumba and TL2, fecal samples were hard to find because no
research had previously been conducted there. We gathered
information on bonobos from villagers or local hunters and
2http://www.bonoboincongo.com/
explored in the forest with local staff moving our camp for
several weeks. We found several old nest sites, and samples were
successfully collected once under the fresh nest groups at each
site in Lac Tumba. A few samples were collected from nest
groups in TL2. Encounter and near-miss with bonobos happened
at Katopa, Oluo, and Bafundo. We could track their footprints
to get fresh fecal samples. When we found feces under nests,
we estimated the age of the nest (most of them were within a
day), the number of nests and the latitude and longitude using
GPS. We also estimated the size (large, medium, small) and
hardness (solid, intermediate, soft: diarrhea-like) to check the
general health condition. In the case of Wamba E1 group, we
checked health status, such as sneezing or nasal mucus, for each
individual everyday. Each thumb-sized sample was put into silica
gel and alcohol tube using twigs from fallen branches.
Serological Surveillance for LCV
Infection in Chimpanzees
Serological surveillance for LCV infection in chimpanzees was
conducted using an enzyme immunoassay (EIA) for detecting
anti-EBV IgG since it was shown to be cross-reacted with the
chimpanzee LCV (Kooriyama et al., 2013). EIA analysis was
outsourced to Tokai Chuo Laboratory (ISO15189: 2003) in
FALCO Biosystems, Ltd, Japan (Kooriyama et al., 2013).
Extraction and Purification of IgA From
Fecal Samples
Extraction of IgA from fecal samples was performed as previously
described (Okhuysen et al., 1995; Santiago et al., 2003) with
modifications. Fecal samples (∼10 g) were resuspended (10%
[wt/vol]) in T-PER Tissue Protein Extraction Reagent (Thermo
SCIENTIFIC) containing 1% aprotinin (SIGMA) and 1%
protease inhibitor cocktail (SIGMA), vortexed, and centrifuged
twice at 3,000 rpm (1,600 g) for 15 min at 4◦C and at 6,000 rpm
(3,300 g) for 30 min at 4◦C to extensively remove solid matter.
The supernatants were added with 1% aprotinin (SIGMA) and
1% protease inhibitor cocktail (SIGMA) and were stored at
−80◦C until use.
Purification of Igs from the supernatants was performed by
NAb protein A/G Spin Kit (Thermo SCIENTIFIC) according
to the manufacturer’s instruction. Column in a collection tube
was centrifuged at 5,000 g for 1 min at room temperature (RT)
to remove the storage solution. Four hundred µl of a binding
buffer was added to the column/collection tubes to equilibrate the
column. The column/collection tubes were centrifuged at 5,000 g
for 1 min at RT to remove the binding buffer. Five hundred µl
of antibody-containing fecal samples were added to the column,
incubated at RT for 10 min. The column in the new collection
tube was centrifuged at 5,000 g for 1 min at RT to remove the
unbound sample components. The columns were washed with
the binding buffer three times. An elution buffer was added
to the columns/collection tube containing a neutralizing buffer,
centrifuged at 5,000 g for 1 min at RT. Buffer was exchanged by
Zeba desalt spin columns. The antibody-containing samples in
the storage buffer were stored at 4◦C until use.
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FIGURE 1 | Detection of IgG and IgA antibodies against LCV VCA in sera and feces of captive chimpanzees. Antibodies against LCV VCA in sera (A,B)
and feces (C,D) of captive chimpanzees were evaluated by ELISA. Results shown are representative of three independent experiments. The results of anti-VCA IgG
(A,C) and the anti-VCA IgA (B,D) are indicated, respectively.
FIGURE 2 | Detection of IgG and IgA antibodies against LCV EA in sera and feces of captive chimpanzees. Antibodies against LCV EA in sera (A,B) and
feces (C,D) of captive chimpanzees were evaluated by ELISA. Results shown are representative of three independent experiments. The results of anti-EA IgG (A,C)
and the anti-EA IgA (B,D) are indicated, respectively.
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Detection of Antibodies Taken from Sera
and Feces against LCV by
Enzyme-Linked Immunosorbent Assay
(ELISA)
The anti-LCV IgA antibodies from sera and feces were evaluated
by using EBV the viral capsid antigen (VCA) IgA ELISA Kit
(IBL INTERNATIONAL). The assay was performed according
to the manufacturer’s instruction. To detect the anti-LCV VCA
IgA in the samples from chimpanzees and bonobos, they were
diluted in a dilution buffer, applied to the wells in serial
dilutions, incubated for 1 h at 37◦C and washed with the wash
buffer three times. Anti-human IgA conjugated to horseradish
peroxidase (HRP) was added to each well and incubated for
1 h at 37◦C. Each well was washed with a wash buffer three
times. Tetramethylbenzidine (TMB) substrate solution was added
to each well and incubated for 30 min RT, and then the
reaction was stopped with TMB stop solution. Optical density
was measured using an enzyme-linked immunosorbent assay
(ELISA) reader at 450 nm. Concentration of an anti-EBV
IgG antibody from fecal samples was assessed by using the
EBV VCA IgA ELISA kit with slight modifications. An EBV
VCA antibody (abcam) was used as a standard and an HRP-
human IgG Fab antibody (BETHYL) was used as a secondary
antibody.
Concentration of an anti-EBV early antigen (EA) IgA
antibody from sera and fecal samples was assessed by using
ELISA construction system (IMMUNOtek) and EBV EA
protein (abcam). The assay was performed according to the
manufacturer’s instruction with a slight modification. The EBV
EA antigen was dissolved in binding buffer (ZeptoBind). To
detect the anti-EA IgA in sera and fecal samples, 96-well ELISA
plates were coated with an EBV EA antigen and were incubated
for overnight at 4◦C. The plates were treated with blocking
solution (ZeptoBlock) for 2 h at RT, then with coating buffer
(ZeptoCaot) for 1 h at RT and dried for overnight at RT. The
plates and a desiccant pillow were stored in a resealable bag
at 4◦C until use. To detect the anti-EBV EA IgA, the samples
were diluted in a dilution buffer, applied to the wells in serial
dilutions, incubated for 1 h at 37◦C and washed with the
wash buffer three times. The anti-human IgA conjugated with
HRP was added to each well and incubated for 1 h at 37◦C.
Each well was washed with a wash buffer three times. TMB
substrate solution was added to each well and incubated for
30 min at RT, and then the reaction was stopped with TMB stop
solution. Optical density was measured with an ELISA reader at
450 nm.
Detection of Fecal Antibodies against
LCV by Western Blotting (WB) Analysis
The anti-LCV IgA from plasma or fecal samples was
assessed by using Can Get Signal system (TOYOBO).
Enhanced chemiluminescent was performed according to
the manufacturer’s instructions and as previously described
(Santiago et al., 2002, 2003) with slight modifications. WB strips
transferred with total EBV proteins (Abcam) were blocked with
5% bovine serum albumin (SIGMA) in PBS-Tween (PBS-T) for
1 h at RT, and washed with the PBS-T three times. The blot strips
were incubated with sera or purified fecal extracts in Can Get
Signal solution 1 for 1 h at RT, and washed with the PBS-T three
times. The blot strips were reacted with the goat anti-human
IgG+IgM+IgA (1:200,000) conjugated to HRP (BETHYL) for
1 h at RT, and washed with PBS-T three times. The strips were
examined for chemiluminescence by using an ECL Western
Blotting Detection system (Amersham). A monoclonal antibody
against EBV EA (Abcam) was used as a positive control (PC) for
the assay. The EBV-negative human serum and the fecal elute
obtained from a chimpanzee negative for the LCV EA antibody
were employed as a negative control (NC), respectively.
FIGURE 3 | Relationship between the concentration of the anti-VCA and EA IgA and IgG antibodies in the sera of captive chimpanzees. The data
regarding the concentration of IgA and IgG antibodies against LCV VCA (A) and EA (B) in the sera of captive chimpanzees as measured by ELISA were plotted.
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FIGURE 4 | Detection of LCV EA-specific antibodies in sera and fecal
samples from captive chimpanzees by WB analysis. The anti-LCV EA
antibodies in sera (A) and feces (B) of captive chimpanzees were examined
for the reactivity to EBV EA by WB analysis. PC and NC indicate positive and
negative controls, respectively.
RESULTS
Comparison between Anti-LCV IgG and
IgA Antibodies in Sera and Fecal
Samples of Captive Chimpanzees
The purpose of this study was to survey prevalence of LCV
infection in wild bonobos. However, it was not possible to
perform usual serological surveillance since sera samples of
the bonobos were unavailable. A previous report showed that
some peoples infected with EBV were positive for anti-EBV IgA
(Hanlon et al., 2014), which led us to come up with an idea that
anti-LCV IgA could be detected in the feces elutes. In order to
test the possibility, we needed to overcome the following hurdles;
(i) if the great apes infected with LCV could become positive
for IgA as well as IgG against LCV in sera similar to human
cases, (ii) if the anti-LCV IgA level could be correlated with that
of IgG, considering the possibility that individuals infected with
LCV were negative for anti-LCV IgA while positive for anti-LCV
IgG, and (iii) if the IgA and/or IgG could be efficiently eluted
and detectable in the feces. We initially sought to address these
questions.
In our recent pilot study of serological surveillance toward
zoonotic and anthropozoonotic agents in captive chimpanzees at
KUPRI, most of our captive chimpanzees were seropositive for
LCV (Kooriyama et al., 2013). In order to ask if the great apes
infected with LCV could become positive for IgA as well as IgG
against LCV in sera similar to human cases, the sera from the
chimpanzees positive for anti-LCV IgG were evaluated for the
anti-LCV IgA. EBV infection in humans is usually determined
by detecting antibodies to VCA (van Grunsven et al., 1993).
Moreover, it was reported that antibodies reactive to EBV EA as
well as VCA was detected in apes such as orangutans, gorillas,
and chimpanzees (Ishida and Yamamoto, 1987). Thus, we tested
both the antigens in order to evaluate LCV-specific antibodies
in the sera. We found that VCA-specific IgA antibody was
detected in the sera of the chimpanzees positive for anti-VCA
IgG (Figures 1A,B) and that VCA-specific IgA but not IgG was
detected in the feces of six of nine individuals (Figures 1C,D).
Similarly, EA-specific IgA as well as IgG antibodies were observed
in the sera of these chimpanzees while the amounts of the EA-
specific IgA were much greater than those of VCA-specific IgA
(Figures 2A,B). In addition, the amounts of the EA-specific
but not anti-VCA IgA and IgG among the individuals were
significantly correlated (Figure 3). Importantly, the chimpanzees
exhibited greater and detectable EA-specific IgA but not IgG
antibody in their feces as compared with the case of the anti-
VCA IgA (Figures 2C,D). These results indicated that the LCV-
infected chimpanzees became seropositive for IgA as well as IgG
against LCV, and also that the LCV EA-specific IgA but not IgG
was efficiently detected in the feces. In order to confirm the
reliability of the anti-EA IgA in the sera and the feces as detected
by the ELISA assay, the samples were also subjected for WB
analysis. We observed EA-specific bands in both the sera and the
feces samples from the individuals positive for the anti-LCV EA
IgA by the ELISA assay (Figure 4). Taken together, we concluded
that the detection of fecal anti-LCV IgA was likely reliable and
feasible for epidemiological surveillance of LCV prevalence in the
great apes.
Epidemiological Surveillance of LCV in
Fecal Samples of Wild Bonobos
We examined 98 fecal samples from wild bonobos across
multiple field sites in the DRC for the prevalence of LCV
infection. Figure 5 shows sample numbers and locations where
individual feces were collected. In order to recognize bonobo
feces individually we performed microsatellite marker analysis
by using DNA obtained from fecal samples (Kawamoto et al.,
2013). Since only two fecal samples were derived from the same
individual, we deleted one of them for further epidemiological
analysis of LCV infection. As a result, 29 fecal samples from
Wamba, 35 from TL2, 17 from Lomako, and 17 from Lac Tumba
were employed for further analyses.
Next, we sought to evaluate LCV EA and VCA-specific
antibodies in the bonobos’ fecal samples as measured by
the ELISA method. As shown in Table 1, 21% and 31% of
wild bonobos had detectable LCV VCA and EA-specific IgA,
respectively. Importantly, the prevalence of LCV antibodies was
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FIGURE 5 | Geographical map showing fecal sample collection sites in DRC. Collection of 98 feces was performed as described in Section “Materials and
Methods.”
extensively varied among the sampled populations; 8 of 29 (28%),
8 of 17 (47%), and 13 of 35 (37%) were positive for anti-EA IgA in
Wamba, Lomako and TL2, respectively, while only 1 of 17 (0.1%)
in Lac Tumba was positive. The results of anti-VCA antibody
examination were basically consistent with but less in their titers
than those of anti-EA antibody, which was consistent with our
finding in captive chimpanzees as shown in Figures 1 and 2. The
concentration of the anti-VCA and EA antibodies in the feces
of bonobos was indicated in Figure 6. We did not observe any
obvious differences in the IgA concentration among the sampled
populations (Figures 6A,B).
DISCUSSION
In the present study, we sought to determine the epidemiological
status of LCV in wild bonobos. We first examined whether
LCV-specific IgA and IgG antibodies could be induced in the
sera from the LCV-infected apes and if so, whether the IgA
could be detected in the feces as well as the sera. In parallel,
we needed to establish a sensitive detection system for the
anti-LCV IgA, which was capable of evaluating fecal samples
TABLE 1 | Frequency of wild bonobos positive for anti-LCV antibodies in
each habitat.
Area Frequency of individuals
positive for VCA antibody
Frequency of individuals
positive for EA antibody
Wamba 6/29 (21%) 8/29 (28%)
Lomako 3/17 (19%) 8/17 (47%)
TL2 12/35 (34%) 13/35 (37%)
LacTumba 0/17 (0%) 1/17 (0.1%)
Sum 21/98 (21%) 30/98 (31%)
VCA and EA indicate viral capsid antigen and early antigen, respectively.
FIGURE 6 | Comparison among the sampled populations of wild
bonobos in terms of the concentration of the anti-VCA and EA IgA
antibodies in their feces. The plotted data indicate the concentration of IgA
antibodies against LCV VCA (A) and EA (B) in the feces of wild bonobos
habituated in Wamba, Lomako, TL2, and Lac Tumba, respectively, as
measured by ELISA.
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collected in the different populations of bonobos. We found that
IgA against LCV VCA and EA was detectable in both the sera
and the feces of seropositive captive chimpanzees (Figures 1,
2, and 4). Considering the genetic proximity of chimpanzees
and bonobos, it was reasonable to assume that the LCV-specific
IgA in the feces from bonobos would also be detectable in our
ELISA system, in the case of the presence of LCV-infected and
seropositive bonobos. Fortunately, we were able to observe LCV-
specific IgA in the feces of wild bonobos and found that 31% of
the individuals tested were positive for the IgA against the EA
(Table 1), suggesting that the LCV is endemic among bonobos
living in DRC. Considering the possibility that the results might
contain false positive, i.e., positive for LCV-reactive IgA without
LCV infection, we also examined the samples for WB (data not
shown). The results of this study generally confirmed the data
by ELISA, however, one of 26 samples tested actually showed
inconsistent results of ELISA and WB (positive for ELISA while
negative for WB). In fact, the positive result of the sample by
ELISA was just above borderline, so the discrepancy may be due
to lower sensitivity of WB. Taken together, our results in this
study indicate the reliability of the ELISA assay for the detection
of anti-LCV EA IgA in the feces.
Although, the anti-EA IgG and IgA amounts in the
chimpanzee sera were correlated (Figure 3), the anti-EA IgA
amounts in the sera were not correlated with those in the
feces (Figures 2B,D). Fecal IgA is derived from mucosal surface
of gastrointestinal tract and mainly polymeric with secretory
component and J chain (so-called secretory IgA), while serum
IgA/IgG is predominantly monomeric. The secretory and serum
IgA are produced in different manners and locations, which may
be the reason for the incompatibility of the IgA concentration
between sera and feces. Alternatively, it is also possible that
condition of fecal IgA might be differentially affected depending
on the health status of each individual and/or damage of feces
when collecting the samples in the wild.
Interestingly, our finding that the prevalence of LCV
antibodies were not uniform across bonobos populations and
the individuals in Lac Tumba appeared to be almost free of
LCV infection while 28–47% of those in other populations
were positive (Table 1). The results demonstrate that LCV is
highly disseminated among wild bonobos while the prevalence
is remarkably diverse in their population-dependent manner.
Our findings are significant as they highlight another
pressure that threatens the survival of wild bonobos, which are
endangered. Infectious diseases, along with poaching and habitat
loss present major overlapping and interconnected threats to
the survival of African great apes. Naturally occurring zoonotic
pathogens, such as Ebola virus, SIV, malaria parasites, as well
as anthropozoonotic pathogens causing respiratory diseases are
known to contribute to mortality in the great apes (Walsh
et al., 2003). Epidemiological information regarding potential
life-threatening infectious diseases will be indispensable in the
development of conservation strategies for wild bonobos. The
protocols that we established in this study for detecting LCV-
specific fecal IgA will also be applicable for the surveillance
of air-born respiratory viruses infection, by which the presence
of the antiviral IgA in the feces may be anticipated. Further
epidemiological analyses of the pathogenic agents will provide
information as for the risks in the outbreak of infectious diseases
including anthropozoonoses, which will help propose evidence-
based and optimized policies regarding conservation strategies of
wild bonobos, as well as understanding the myriad links between
health in the human-wildlife interface.
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